31P Magnetic Resonance Spectroscopy Fructose Study
31PMRS_FRU
Investigating the Effects of an Oral Fructose Challenge on Hepatic ATP Reserves in Healthy Volunteers
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of this study is to determine the effects of an oral fructose challenge on liver adenosine triphosphate (ATP) reserves using 31P magnetic resonance spectroscopy (MRS) as a potential measure measure of liver health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Mar 2011
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 12, 2014
CompletedFirst Posted
Study publicly available on registry
August 15, 2014
CompletedAugust 15, 2014
August 1, 2014
2.5 years
August 12, 2014
August 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hepatic ATP reserves following an oral fructose challenge
Monitor hepatic ATP levels following an oral fructose challenge using 31P magnetic resonance spectroscopy
2 hours post prandial
Secondary Outcomes (1)
Correlate hepatic ATP depletion / recovery with BMI, liver lipids and liver glycogen
2 hours post prandial
Study Arms (1)
Fructose
EXPERIMENTALOral Fructose Challenge (75 g fructose in 500 ml water) followed by 75 minutes 31P MRS
Interventions
Oral Fructose Challenge (75 g fructose in 500 ml water) following overnight fast
Eligibility Criteria
You may qualify if:
- Male
- Age 18 - 30
- BMI 20 - 27 kg/m\^2
- Healthy
You may not qualify if:
- Smokers
- Liver disease or Metabolic Disorders
- Metal implants (not suitable for MRI)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stephen Bawdenlead
- Biotechnology and Biological Sciences Research Councilcollaborator
- Unilever R&Dcollaborator
Study Sites (1)
University of Nottingham
Nottingham, Nottinghamshire, NG7 2RD, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luca Marciani
University of Nottingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- CASE studentship researcher
Study Record Dates
First Submitted
August 12, 2014
First Posted
August 15, 2014
Study Start
March 1, 2011
Primary Completion
September 1, 2013
Study Completion
December 1, 2013
Last Updated
August 15, 2014
Record last verified: 2014-08